Veradigm Eyes Operational Improvements After Not Finding a Buyer
The company’s directors had talks with more than 30 entities since announcing a strategic review last spring.
Read More
An Arm and a Leg: The Struggle To Afford Insurance in 2026 Hits Home
“An Arm and a Leg” senior producer Emily Pisacreta recently lost a job that provided her with health insurance. So now, for the first time, she will be signing up for Obamacare. Her search is off to a rocky start. Pisacreta gives listeners a sobering look at how the high price of health insurance plans…
KFF Health News’ ‘What the Health?’: Congress Punts to a Looming Lame-Duck Session
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
AI Won’t Fix American Healthcare on Its Own, But It Can Help Us Close the Gap
We can’t ignore what AI makes possible: faster diagnoses, smarter workflows, better use of limited resources, and more personalized care at scale. If we get this right, we can build a system that works better for everyone, not just the few who can afford concierge care or live near major medical centers. The post AI…
Alnylam Drug Approval Brings Cardiomyopathy Competition to Pfizer, BridgeBio Pharma
Amvuttra, an Alnylam drug approved to treat nerve pain from transthyretin amyloidosis, is now FDA-approved for treating cardiomyopathy caused by this disease. The approval brings Amvuttra to a much bigger market, but it must compete with a blockbuster Pfizer drug already established as the standard of care. The post Alnylam Drug Approval Brings Cardiomyopathy Competition…
Video: Battle of the Bulge – Wegovy vs. Zepbound
The Glp-1 battle heats with new preliminary data from Eli Lilly showing that patients using its weight loss drug Zepbound lost more weight on average in 72 weeks than those on Novo Nordisk’s Wegovy. The post Video: Battle of the Bulge – Wegovy vs. Zepbound appeared first on MedCity News.
Ballad Health CIO: Tech Should ‘Fade into the Background’
Pam Austin, CIO of Ballad Health, detailed how her health system is helping clinicians spend less time on screens and more time with patients. The post Ballad Health CIO: Tech Should ‘Fade into the Background’ appeared first on MedCity News.
Phygital Healthcare Experiences? What Hospitals Can Learn from Retail’s CX Standards
Retail has shown what’s possible when human-centered technology is used to improve in-person experiences. Now it’s healthcare’s turn. The post Phygital Healthcare Experiences? What Hospitals Can Learn from Retail’s CX Standards appeared first on MedCity News.
Tracy DeTomasi, Callisto
Callisto is a non-profit tech company that helps survivors of sexual violence identify repeat offenders. The company was started a few years back by Jess Ladd and Tracy DeTomasi took over as CEO a few years back, It focuses on college campuses where 90% of assaults are perpetrated by repeat offenders, who on average commit…
In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say
The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half of the security council’s staff have been laid off or left. This is dangerous say former health security officials. The post In Axing mRNA Contract, Trump…